Recently, the Pre ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio (Third Edition) organized by the American Bar Association (ABA) was officially published. Dr. PENG Kunpeng, a partner of Unitalen, as a specially invited author, participated in the writing of the content related to the Chinese drug registration and patent linkage system therein.